Literature DB >> 6196961

Anatomy and pathology of the male pelvis by magnetic resonance imaging.

H Hricak, R D Williams, D B Spring, K L Moon, M W Hedgcock, R A Watson, L E Crooks.   

Abstract

Magnetic resonance imaging (MRI) of the male pelvis was performed in 25 subjects: five normal volunteers; six patients with carcinoma of the bladder; nine with benign nodular hyperplasia (including five with concomitant bladder carcinoma); nine with prostatic carcinoma; and one with a lymphocele after radical prostatectomy. The display of normal anatomy is enhanced by the ability of the MRI device to provide images in direct transverse, sagittal, and coronal planes. Sessile and pedunculated types of bladder carcinoma are readily shown due to the superior ability of MRI for soft-tissue characterization. Direct sagittal scans are advantageous for evaluation of tumors at the bladder base, and by combining two different planes of images, the extent of the neoplasm is better delineated. In the analysis of the prostate, MRI displays the gland in three dimensions and therefore allows accurate volumetric measurements. The greatest potential of MRI seems to be its ability to detect pathology confined to the gland. However, it is not yet known if a neoplastic nodule can be differentiated from chronic prostatitis. Unlike x-ray CT, metallic clips produce no streaking artifacts, giving MRI a definite advantage in the evaluation of patients after radical surgery. These observations were made on a small number of patients. If the results are confirmed with a larger number of patients, MRI will assume a prominent role in the clinical evaluation of bladder and prostate cancer.

Entities:  

Mesh:

Year:  1983        PMID: 6196961     DOI: 10.2214/ajr.141.6.1101

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  30 in total

Review 1.  The normal post-surgical anatomy of the male pelvis following radical prostatectomy as assessed by magnetic resonance imaging.

Authors:  Steven D Allen; Alan Thompson; S Aslam Sohaib
Journal:  Eur Radiol       Date:  2008-02-13       Impact factor: 5.315

2.  Magnetic resonance tomography of the pelvis.

Authors:  F W Smith
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

Review 3.  Nuclear magnetic resonance imaging.

Authors:  R E Steiner
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-20

4.  Clinical use of a nonferromagnetic needle for magnetic resonance-guided biopsy.

Authors:  P R Mueller; D D Stark; J F Simeone; S Saini; P F Hahn; E Steiner; P Beaulieu; J Wittenberg; J T Ferrucci
Journal:  Gastrointest Radiol       Date:  1989

5.  The diagnostic significance of magnetic resonance imaging in prostatic tumours.

Authors:  N Jaeger; A Bockisch; B Hünermann; H Biersack; W Vahlensieck
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

6.  Imaging and compartmental classification of solid pelvic tumours in children.

Authors:  C Hugosson; R Nyman; B Jacobsson; H Jorulf; P McDonald; K Sackey
Journal:  Pediatr Radiol       Date:  1996-12

Review 7.  Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.

Authors:  Kristine Glunde; Dmitri Artemov; Marie-France Penet; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 8.  Multiparametric magnetic resonance imaging: Overview of the technique, clinical applications in prostate biopsy and future directions.

Authors:  Hüseyin Cihan Demirel; John Warren Davis
Journal:  Turk J Urol       Date:  2018-03-01

Review 9.  Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer.

Authors:  Michael A Jacobs; Ronald Ouwerkerk; Kyle Petrowski; Katarzyna J Macura
Journal:  Top Magn Reson Imaging       Date:  2008-12

Review 10.  Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy.

Authors:  Geoffrey A Sonn; Daniel J Margolis; Leonard S Marks
Journal:  Urol Oncol       Date:  2013-11-13       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.